Galderma rolls out Alastin regenerative skincare across JPAC region

Swiss dermatology company Galderma (SIX: GALD) is expanding its premium regenerative skincare brand Alastin across the Japan and Asia Pacific (JPAC) region, deepening its bet on one of the world's fastest-growing aesthetics markets.

The brand has recently launched in Taiwan and will shortly arrive in Japan. It has also secured approval in Singapore and South Korea, where market introductions are planned for September and November, respectively. The rollout follows earlier Alastin launches in China and Australia, as Galderma builds out what it calls a key growth engine for the group.